Oxytocin research guide
Cyclic nine-residue peptide and oxytocin-receptor ligand
Oxytocin molecular identity, receptor experiments and a controlled social-function trial, with clear boundaries between a peptide and a finished study formulation.
AUS Peptide Supply editorial team01 · Identity
What the name identifies
Oxytocin is a cyclic nonapeptide with a disulfide bond linking its cysteine residues. Molecular identity, receptor activity and the performance of a formulated product are separate evidence questions. A familiar compound name does not confirm the structure or content of a supplied sample.
02 · Evidence position
What the literature can support
Foundational receptor research explains one biological target, while clinical findings depend on population and formulation. The selected large autism trial did not demonstrate a benefit on its primary social-function endpoint. That finding should not be replaced by broad claims about bonding or trust.
03 · Study-level map
Evidence and its limits
Which structural features define the reference molecule?
The PubChem record identifies a nine-residue peptide with a disulfide-linked cyclic structure and an amidated terminus.
Limit: A database structure is a reference identity, not evidence that a batch has the expected structure, content or purity.
What did the receptor-cloning study establish?
The 1992 study described the human oxytocin receptor and an oxytocin-responsive experimental expression system.
Limit: A receptor-system response is not the same endpoint as a behavioural or clinical benefit.
What did the 24-week autism trial find?
The 2021 placebo-controlled trial enrolled 290 children and adolescents and found no significant between-group advantage on its primary social-withdrawal measure.
Limit: The result concerns the studied intranasal formulation and population, not every oxytocin experiment or this research material.
04 · Analytical context
Questions a batch record should answer
- 01Does the identity assessment address the expected disulfide-linked structure and terminal form?
- 02Are peptide content and biological activity measured separately, with their units stated?
- 03Is a formulated-product claim being distinguished from evidence for the actual research material?
05 · Boundary conditions
What this record does not establish
- A general social or behavioural effect cannot be inferred from receptor activity.
- Mass in milligrams is not automatically an activity-unit specification.
- No verified APS CoA is available for the associated product at publication.
Sources checked
- 1.Oxytocin — PubChem CID 439302
NIH PubChem · 2026 · Chemical database
- 2.Structure and expression of a human oxytocin receptor
Kimura et al. — Nature / PubMed · 1992 · Primary study
- 3.Intranasal Oxytocin in Children and Adolescents with Autism Spectrum Disorder
Sikich et al. — New England Journal of Medicine · 2021 · Primary study